دورية أكاديمية

DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure

التفاصيل البيبلوغرافية
العنوان: DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure
المؤلفون: Florence Boisnard, Christine Manson, Laurence Serradell, Denis Macina
المصدر: Expert Review of Vaccines, Vol 22, Iss 1, Pp 1196-1213 (2023)
بيانات النشر: Taylor & Francis Group, 2023.
سنة النشر: 2023
المجموعة: LCC:Internal medicine
مصطلحات موضوعية: Clinical trial, effectiveness, fully liquid, hexavalent, immunogenicity, pertussis, Internal medicine, RC31-1245
الوصف: ABSTRACTIntroduction Hexaxim® is fully liquid, hexavalent, combination vaccine that provides immunization against diphtheria, tetanus, pertussis (whooping cough), polio, hepatitis B, and invasive diseases caused by Haemophilus influenzae type b. Combination vaccines such as Hexaxim reduce the number of injections needed, improving both vaccination compliance and operational efficiency.Areas covered Safety and immunogenicity data were reviewed from >25 clinical trials involving approximately 7200 infants/toddlers, identified using PubMed searches to April 2023. These trials have evaluated a diverse range of primary series and booster schedules, including antibody persistence, co-administration of Hexaxim with other routine pediatric vaccines, and specific populations (born to Tdap-vaccinated women, preterm, and immunocompromised infants). Lastly, post-marketing surveillance and real-world effectiveness data were assessed.Expert opinion An extensive program of clinical development prior to licensure demonstrated favorable vaccine safety and good immunogenicity of each antigen, and Hexaxim was first approved for use in 2012. In the 10 years since licensure, Hexaxim has been adopted widely, with more than 180 million doses distributed worldwide. The widespread use of this hexavalent vaccine is a crucial tool in the ongoing and future control of six pediatric infectious diseases globally.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 14760584
1744-8395
1476-0584
Relation: https://doaj.org/toc/1476-0584; https://doaj.org/toc/1744-8395
DOI: 10.1080/14760584.2023.2280236
URL الوصول: https://doaj.org/article/88c5e3c0b8e84d7e91627b867cf97313
رقم الأكسشن: edsdoj.88c5e3c0b8e84d7e91627b867cf97313
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14760584
17448395
DOI:10.1080/14760584.2023.2280236